Skip to main content

COVID-19 Advisory: Visitor restrictions are in place for all Phoenix Children’s locations. Masks are required for all visitors and for patients ages 2+. For more information, visit our COVID-19 Resource Center.

Clinical Research & Trial

Clinical Research gives the opportunity to explore treatments for patients with complex medical conditions.

Phoenix Children’s Hospital is exploring the outcome with Topotecan Episcleral Plaque for Treatment of Retinoblastoma. This study is FDA approved and will evaluate the safety and efficacy of using a sustained release episcleral chemotherapy delivery system for kids with retinoblastoma that is just diagnosed or recurrent retinoblastoma after other treatments.

For details regarding the study please see https://clinicaltrials.gov/ct2/show/NCT04156347

The study principal investigator is Aparna Ramasubramanian, MD

The study will be conducted at:
Phoenix Children’s Hospital
1919 E Thomas Road, Phoenix, AZ, 85016

For further details, please contact:
Kimberly Winfrey, RN
Retinoblastoma Coordinator
Phoenix Children’s Hospital
602-933-EYES (3937).

Share this page